Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohamad Amin Khadembashiri"'
Autor:
Mohamad Mehdi Khadembashiri, Shahrzad Mohseni, Hamid Harandi, Mahnaz Pejman Sani, Mohamad Amin Khadembashiri, Rasha Atlasi, SeyedAhmad SeyedAlinaghi, Mohammadreza Mohajeri- Tehrani, Bagher Larijani
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveThis systematic review and meta-analysis was conducted to compare the benefits of adrenalectomy and conservative treatment for comorbidities associated with mild autonomous cortisol secretion (MACS) in patients diagnosed with MACS.Background
Externí odkaz:
https://doaj.org/article/b4f163ae5614430592f3037683ae3c04
Autor:
Parnian Shobeiri, Razman Arabzadeh Bahri, Mohamad Mehdi Khadembashiri, Mohamad Amin Khadembashiri, Saba Maleki, Mohammad Eslami, Marzie Khalili Dehkordi, Amir Hossein Behnoush, Nima Rezaei
Publikováno v:
Cancer Reports, Vol 7, Iss 3, Pp n/a-n/a (2024)
Abstract Background Cholangiocarcinoma (CCA), as a rare malignancy of the biliary tree, has a poor prognosis most of the time. CCA is highly epigenetically regulated and several long non‐coding RNAs (lncRNA) have been investigated to have a diagnos
Externí odkaz:
https://doaj.org/article/5f6ae33a623141f8890dfaa74eb94d63
Autor:
Hanieh Radkhah, Ensieh Sadat Mansouri, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Ali Sheikhy, Mohamad Mehdi Khadembashiri, Mohamad Amin Khadembashiri, Mohamad Eslami, Tara Mahmoodi, Behnaz Inanloo, Arash Pour Mohammad
Publikováno v:
Immunity, Inflammation and Disease, Vol 11, Iss 9, Pp n/a-n/a (2023)
Abstract Background Pulmonary thromboembolism (PTE) is a common complication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which raises the COVID‐19 disease's fatality rate from 3% to 45%. Nevertheless, due to fairly indistin
Externí odkaz:
https://doaj.org/article/32bf9987876f4f02bc67133518d0a83e
Autor:
Mohamad Mehdi Khadembashiri, Erfan Ghasemi, Mohamad Amin Khadembashiri, Sina Azadnajafabad, Sahar Saeedi Moghaddam, Mohamad Eslami, Mohammad-Mahdi Rashidi, Mohammadreza Naderian, Zahra Esfahani, Naser Ahmadi, Nazila Rezaei, Sahar Mohammadi Fateh, Farzad Kompani, Bagher Larijani, Farshad Farzadfar
Background Kidney cancer is a prevalent cancer worldwide. The incidence and mortality rates of Kidney Cancer (KC) have risen in recent decades. The quality of care provided to KC patients is a concern for public health. Considering the importance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88068eff5f8b9ba20a979e920a7fe7e7
https://doi.org/10.21203/rs.3.rs-2538913/v1
https://doi.org/10.21203/rs.3.rs-2538913/v1
